Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ella Daly

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Psychiatry Research|April 5, 2023
Predictors of response and remission in patients with treatment-resistant depression: A post hoc pooled analysis of two acute trials of esketamine nasal sprayIbrahim Turkoz, J Craig Nelson, Samuel T Wilkinson, et al.
Biological Psychiatry|December 29, 2015
Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled StudyJaskaran B Singh, Maggie Fedgchin, Ella Daly, et al.
The American Journal of Psychiatry|April 6, 2013
Increase in work productivity of depressed individuals with improvement in depressive symptom severityMadhukar H Trivedi, David W Morris, Stephen R Wisniewski, et al.
The Journal of Nervous and Mental Disease|December 23, 2021
A Choice-Based Conjoint Analysis of the Psychiatrist Decision-Making Process Used in Determining When to Discharge Adults With Major Depressive Disorder Hospitalized for Active Suicidal Ideation With IntentJennifer Voelker, Samuel T Wilkinson, Eva G Katz, et al.
CNS Drugs|July 8, 2021
Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III StudiesRichard L Doty, Vanina Popova, Crystal Wylie, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Psychiatry Research|April 5, 2023
Predictors of response and remission in patients with treatment-resistant depression: A post hoc pooled analysis of two acute trials of esketamine nasal sprayIbrahim Turkoz, J Craig Nelson, Samuel T Wilkinson, et al.
Biological Psychiatry|December 29, 2015
Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled StudyJaskaran B Singh, Maggie Fedgchin, Ella Daly, et al.
The American Journal of Psychiatry|April 6, 2013
Increase in work productivity of depressed individuals with improvement in depressive symptom severityMadhukar H Trivedi, David W Morris, Stephen R Wisniewski, et al.
The Journal of Nervous and Mental Disease|December 23, 2021
A Choice-Based Conjoint Analysis of the Psychiatrist Decision-Making Process Used in Determining When to Discharge Adults With Major Depressive Disorder Hospitalized for Active Suicidal Ideation With IntentJennifer Voelker, Samuel T Wilkinson, Eva G Katz, et al.
CNS Drugs|July 8, 2021
Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III StudiesRichard L Doty, Vanina Popova, Crystal Wylie, et al.
Pageof 3